中文版
js_thumb bannerPic
/
Profile

Macro micro-test

Macro & Micro Test, founded in 2010 in Beijing, a company being committed to the research, development and production of new detection technologies and novel in vitro diagnostic reagents based on its self-developed patent technologies. With its continuous endeavors and achievements, the company has established three industrial bases in Beijing, Nantong and Suzhou with GMP workshops and R&D laboratories around 16,000 m2 in total. The company has successively undertaken quite a few significant projects such as the National Infectious Disease Project, the National High-Tech R&D Program (Program 863), the National Key Basic R&D Program (Program 973) and the National Natural Science Foundation of China. Moreover, close collaboration has been established with top scientific institutions in China, and over 20 national patents has been obtained. Up to now, more than 200 diagnostic products have been developed covering infectious disease prevention and control, reproductive health testing, genetic disease testing, personalized drug gene testing, COVID-19 detection and other business fields. 
Macro & Micro Test has molecular diagnosis, immunization, POCT and other technology platforms with professional R&D, production, management and operation teams, "high-tech enterprise" certified by Jiangsu Province. It has passed TUV EN ISO13485:2016, CMD YY/T 0287-2017 IDT IS 13485:2016, GB/T 19001-2016 IDT ISO 9001:2015 and some products CE certification.

Enterprise aim:
Precise diagnosis shapes a better life
Core values:
Responsibility, integrity, innovation, cooperation, persistence
Vision:
To provide first-class medical products and services for mankind, benefit the society and employee

1 1
2 2
3 3

Corporate purposes

"Accurate diagnosis shapes a better life"

The yearning for a better life is the biggest dream of mankind all the time. A healthy body is the primary guarantee for a good life, and one of the greatest threats to life and health comes from disease. There are many factors that cause diseases, but their essence can be attributed to the genetic level. Macroscopic life, microscopic observation of molecules. We firmly believe that only by developing accurate diagnostic reagents at the microscopic gene level and molecular level can the macroscopic life be better. Keep your original intention forever, and always have it. We will adhere to the original intention of "precise diagnosis to shape a better life", relying on our professional knowledge, research and development of medical products and services, honesty management, and return to the society.

  • corporate vision

    corporate vision

    Provide first-class medical products and services for human health, benefit society and employees

    Business philosophy
  • Corporate values

    Corporate values

    Responsibility: People-oriented, quality wins

    Honesty: treat each other with sincerity, beginning and ending

    Innovation: Active learning, the courage to try and make mistakes

    Cooperation: equality and mutual benefit, mutual care

    Perseverance: wholeheartedly, keep improving

    Service philosophy
  • 2020

    Continuous development ...
  • 2019

    Passed medical device quality management system certification; applied for 10 patents.
  • 2018

    Apply for 2 patents.
  • 2017

    Transfer of hereditary keratitis detection technology; applied for 4 patents.
  • 2016

    Jiangsu Macro&Micro-Test Med-Tech Co., Ltd. was established to focus on the development, production and sales of in vitro diagnostic reagents for precision medicine and POCT.
  • 2015

    Applied for 5 patents and transferred high-throughput capture sequencing technology to Zhenao Group.
  • 2014

    Successfully developed various genetic disease detection kits, such as WILSON syndrome, deafness, and hereditary keratitis.
    Cooperated with the Institute of Theoretical Physics of the Chinese Academy of Sciences and the Chinese Center for Disease Control and Prevention to develop a new near-infrared fluorescence tomography technology platform, and applied for 6 patents.
  • 2013

    Successfully developed various drug metabolism test kits such as clopidogrel and warfarin medication guide kits.Transfer of intellectual property rights for tumor-targeted drug products.
  • 2012

    Successfully developed KRAS, ALK,ROS1, CKIT and other tumor drug guidance kits, applied for 3 patents.
  • 2011

    Successfully developed EGFR, BRAF and other tumor drug guidance kits, and applied for 2 patents.
  • 2010

    Beijing Hongwei Tesi Biological Technology Co., Ltd. was incorporated.
Search
Search

Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou
Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing
Contact number:
+86-10-80497001
Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province
Contact number:
+86-513-80562882
Company email: info@hongweitest.com

Macro micro-test

WeChat

Copyright © 2021 Jiangsu Macro & Micro-Test Med-Tech Co.,Ltd.苏ICP备18057655号 苏公网安备 32062302000215号 Power by:300.cn
Suspended
返回顶部